![]() |
||||||
|
![]() | Fusion Gene Summary |
![]() | Fusion Gene ORF analysis |
![]() | Fusion Genomic Features |
![]() | Fusion Protein Features |
![]() | Fusion Gene Sequence |
![]() | Fusion Gene PPI analysis |
![]() | Related Drugs |
![]() | Related Diseases |
Fusion gene:FOXP1-IGHM (FusionGDB2 ID:HG27086TG3507) |
Fusion Gene Summary for FOXP1-IGHM |
![]() |
Fusion gene information | Fusion gene name: FOXP1-IGHM | Fusion gene ID: hg27086tg3507 | Hgene | Tgene | Gene symbol | FOXP1 | IGHM | Gene ID | 27086 | 3507 |
Gene name | forkhead box P1 | ||
Synonyms | 12CC4|HSPC215|MFH|QRF1|hFKH1B | ||
Cytomap | ('FOXP1')('IGHM') 3p13 | ||
Type of gene | protein-coding | ||
Description | forkhead box protein P1fork head-related protein like Bglutamine-rich factor 1mac-1-regulated forkhead | ||
Modification date | 20200329 | ||
UniProtAcc | . | P01871 | |
Ensembl transtripts involved in fusion gene | ENST00000318779, ENST00000318789, ENST00000468577, ENST00000472382, ENST00000475937, ENST00000484350, ENST00000491238, ENST00000493089, ENST00000498215, | ||
Fusion gene scores | * DoF score | 34 X 30 X 13=13260 | 42 X 36 X 10=15120 |
# samples | 38 | 43 | |
** MAII score | log2(38/13260*10)=-5.124937546669 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(43/15120*10)=-5.13597766951897 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: FOXP1 [Title/Abstract] AND IGHM [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | FOXP1(71633094)-IGHM(106330063), # samples:1 FOXP1(71633095)-IGHM(106330465), # samples:1 | ||
Anticipated loss of major functional domain due to fusion event. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | FOXP1 | GO:0002903 | negative regulation of B cell apoptotic process | 25267198 |
Hgene | FOXP1 | GO:0010629 | negative regulation of gene expression | 30111844 |
Hgene | FOXP1 | GO:0030316 | osteoclast differentiation | 18799727 |
Hgene | FOXP1 | GO:0032496 | response to lipopolysaccharide | 18799727 |
Hgene | FOXP1 | GO:0032680 | regulation of tumor necrosis factor production | 18799727 |
Hgene | FOXP1 | GO:0035926 | chemokine (C-C motif) ligand 2 secretion | 18799727 |
Hgene | FOXP1 | GO:0036035 | osteoclast development | 18799727 |
Hgene | FOXP1 | GO:0042116 | macrophage activation | 18799727 |
Hgene | FOXP1 | GO:0042117 | monocyte activation | 18799727 |
Hgene | FOXP1 | GO:0045655 | regulation of monocyte differentiation | 15286807 |
Hgene | FOXP1 | GO:0045892 | negative regulation of transcription, DNA-templated | 20950788 |
Hgene | FOXP1 | GO:0050706 | regulation of interleukin-1 beta secretion | 18799727 |
Hgene | FOXP1 | GO:0050727 | regulation of inflammatory response | 18799727 |
Hgene | FOXP1 | GO:0060766 | negative regulation of androgen receptor signaling pathway | 18640093 |
Hgene | FOXP1 | GO:1900424 | regulation of defense response to bacterium | 18799727 |
Hgene | FOXP1 | GO:1901256 | regulation of macrophage colony-stimulating factor production | 18799727 |
Hgene | FOXP1 | GO:2001182 | regulation of interleukin-12 secretion | 18799727 |
![]() * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | Non-Cancer | ERR188374 | FOXP1 | chr3 | 71633094 | - | IGHM | chr14 | 106330063 | - |
ChimerDB4 | Non-Cancer | ERR188374 | FOXP1 | chr3 | 71633095 | - | IGHM | chr14 | 106330465 | - |
Top |
Fusion Gene ORF analysis for FOXP1-IGHM |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
intron-intron | ENST00000318779 | ENST00000390559 | FOXP1 | chr3 | 71633094 | - | IGHM | chr14 | 106330063 | - |
intron-intron | ENST00000318779 | ENST00000390559 | FOXP1 | chr3 | 71633095 | - | IGHM | chr14 | 106330465 | - |
intron-intron | ENST00000318789 | ENST00000390559 | FOXP1 | chr3 | 71633094 | - | IGHM | chr14 | 106330063 | - |
intron-intron | ENST00000318789 | ENST00000390559 | FOXP1 | chr3 | 71633095 | - | IGHM | chr14 | 106330465 | - |
intron-intron | ENST00000468577 | ENST00000390559 | FOXP1 | chr3 | 71633094 | - | IGHM | chr14 | 106330063 | - |
intron-intron | ENST00000468577 | ENST00000390559 | FOXP1 | chr3 | 71633095 | - | IGHM | chr14 | 106330465 | - |
intron-intron | ENST00000472382 | ENST00000390559 | FOXP1 | chr3 | 71633094 | - | IGHM | chr14 | 106330063 | - |
intron-intron | ENST00000472382 | ENST00000390559 | FOXP1 | chr3 | 71633095 | - | IGHM | chr14 | 106330465 | - |
intron-intron | ENST00000475937 | ENST00000390559 | FOXP1 | chr3 | 71633094 | - | IGHM | chr14 | 106330063 | - |
intron-intron | ENST00000475937 | ENST00000390559 | FOXP1 | chr3 | 71633095 | - | IGHM | chr14 | 106330465 | - |
intron-intron | ENST00000484350 | ENST00000390559 | FOXP1 | chr3 | 71633094 | - | IGHM | chr14 | 106330063 | - |
intron-intron | ENST00000484350 | ENST00000390559 | FOXP1 | chr3 | 71633095 | - | IGHM | chr14 | 106330465 | - |
intron-intron | ENST00000491238 | ENST00000390559 | FOXP1 | chr3 | 71633094 | - | IGHM | chr14 | 106330063 | - |
intron-intron | ENST00000491238 | ENST00000390559 | FOXP1 | chr3 | 71633095 | - | IGHM | chr14 | 106330465 | - |
intron-intron | ENST00000493089 | ENST00000390559 | FOXP1 | chr3 | 71633094 | - | IGHM | chr14 | 106330063 | - |
intron-intron | ENST00000493089 | ENST00000390559 | FOXP1 | chr3 | 71633095 | - | IGHM | chr14 | 106330465 | - |
intron-intron | ENST00000498215 | ENST00000390559 | FOXP1 | chr3 | 71633094 | - | IGHM | chr14 | 106330063 | - |
intron-intron | ENST00000498215 | ENST00000390559 | FOXP1 | chr3 | 71633095 | - | IGHM | chr14 | 106330465 | - |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
Top |
Fusion Genomic Features for FOXP1-IGHM |
![]() |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
Top |
Fusion Protein Features for FOXP1-IGHM |
![]() Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/:71633094/:106330063) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
![]() |
![]() |
Hgene | Tgene |
. | IGHM |
FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. | FUNCTION: Constant region of immunoglobulin heavy chains. Immunoglobulins, also known as antibodies, are membrane-bound or secreted glycoproteins produced by B lymphocytes. In the recognition phase of humoral immunity, the membrane-bound immunoglobulins serve as receptors which, upon binding of a specific antigen, trigger the clonal expansion and differentiation of B lymphocytes into immunoglobulins-secreting plasma cells. Secreted immunoglobulins mediate the effector phase of humoral immunity, which results in the elimination of bound antigens (PubMed:22158414, PubMed:20176268). The antigen binding site is formed by the variable domain of one heavy chain, together with that of its associated light chain. Thus, each immunoglobulin has two antigen binding sites with remarkable affinity for a particular antigen. The variable domains are assembled by a process called V-(D)-J rearrangement and can then be subjected to somatic hypermutations which, after exposure to antigen and selection, allow affinity maturation for a particular antigen (PubMed:17576170, PubMed:20176268). IgM antibodies play an important role in primary defense mechanisms. They have been shown to be involved in early recognition of external invaders like bacteria and viruses, cellular waste and modified self, as well as in recognition and elimination of precancerous and cancerous lesions. The membrane-bound form is found in the majority of normal B-cells alongside with IgD. Membrane-bound IgM induces the phosphorylation of CD79A and CD79B by the Src family of protein tyrosine kinases. It may cause death of cells by apoptosis. It is also found in soluble form, which represents about 30% of the total serum immunoglobulins where it is found almost exclusively as a homopentamer. After the antigen binds to the B-cell receptor, the secreted form is secreted in large amounts (PubMed:3137579, PubMed:16895553). {ECO:0000269|PubMed:3137579, ECO:0000303|PubMed:16895553, ECO:0000303|PubMed:17576170, ECO:0000303|PubMed:20176268, ECO:0000303|PubMed:22158414}. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
Fusion Gene Sequence for FOXP1-IGHM |
![]() |
Top |
Fusion Gene PPI Analysis for FOXP1-IGHM |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for FOXP1-IGHM |
![]() (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Tgene | IGHM | P01871 | DB01593 | Zinc | Small molecule | Approved|Investigational | |
Tgene | IGHM | P01871 | DB14487 | Zinc acetate | Small molecule | Approved|Investigational |
Top |
Related Diseases for FOXP1-IGHM |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | FOXP1 | C3150923 | MENTAL RETARDATION WITH LANGUAGE IMPAIRMENT AND AUTISTIC FEATURES | 16 | CLINGEN;GENOMICS_ENGLAND |
Hgene | FOXP1 | C4013764 | MENTAL RETARDATION WITH LANGUAGE IMPAIRMENT AND WITH OR WITHOUT AUTISTIC FEATURES | 3 | CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT |
Hgene | FOXP1 | C0006413 | Burkitt Lymphoma | 1 | ORPHANET |
Hgene | FOXP1 | C0024232 | Lymphatic Metastasis | 1 | CTD_human |
Hgene | FOXP1 | C0027626 | Neoplasm Invasiveness | 1 | CTD_human |
Hgene | FOXP1 | C0030297 | Pancreatic Neoplasm | 1 | CTD_human |
Hgene | FOXP1 | C0042900 | Vitiligo | 1 | CTD_human |
Hgene | FOXP1 | C0087031 | Juvenile-Onset Still Disease | 1 | CTD_human |
Hgene | FOXP1 | C0242647 | Mucosa-Associated Lymphoid Tissue Lymphoma | 1 | ORPHANET |
Hgene | FOXP1 | C0279628 | Adenocarcinoma Of Esophagus | 1 | CTD_human |
Hgene | FOXP1 | C0346647 | Malignant neoplasm of pancreas | 1 | CTD_human |
Hgene | FOXP1 | C1292769 | Precursor B-cell lymphoblastic leukemia | 1 | ORPHANET |
Hgene | FOXP1 | C1510586 | Autism Spectrum Disorders | 1 | CTD_human |
Hgene | FOXP1 | C1535926 | Neurodevelopmental Disorders | 1 | CTD_human |
Hgene | FOXP1 | C3495559 | Juvenile arthritis | 1 | CTD_human |
Hgene | FOXP1 | C3714758 | Juvenile psoriatic arthritis | 1 | CTD_human |
Hgene | FOXP1 | C4552091 | Polyarthritis, Juvenile, Rheumatoid Factor Negative | 1 | CTD_human |
Hgene | FOXP1 | C4704862 | Polyarthritis, Juvenile, Rheumatoid Factor Positive | 1 | CTD_human |
Tgene | C0001768 | Agammaglobulinemia | 1 | CTD_human;GENOMICS_ENGLAND | |
Tgene | C1832241 | Agammaglobulinemia, non-Bruton type | 1 | ORPHANET | |
Tgene | C3152144 | AGAMMAGLOBULINEMIA 1, AUTOSOMAL RECESSIVE | 1 | GENOMICS_ENGLAND | |
Tgene | C4016215 | AGAMMAGLOBULINEMIA 1 | 1 | GENOMICS_ENGLAND |